Gilead’s remdesivir improves recovery time of coronavirus patients in NIH trial

The government’s first rigorous clinical trial of the experimental drug remdesivir as a coronavirus treatment delivered mixed results to the medical community Wednesday — but rallied stock markets and raised hopes that an early weapon to help some patients was at hand. The preliminary results, disclosed at the White House by Anthony Fauci, chief of […]